EWSR1 and Ewing sarcoma: However, the discovery of novel treatment opportunities may not be imminent because ES is characterized by a recurrent EWS/ETS chromosomal translocation (EWS-FLI1 in most of the cases) but otherwise an overall stable genome (23), leading to a general paucity of druggable mutations.